Richard Haubrich, MD

Vice President
Gilead Sciences
Foster City, California, United States

Gilead Sciences (Employee, Shareholder)

Presentation(s):

• 38 - Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality

  On Demand